These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 25384569

  • 1. Evaluation of melatonin treatment in primary culture of canine mammary tumors.
    Lopes JR, Maschio LB, Jardim-Perassi BV, Moschetta MG, Ferreira LC, Martins GR, Gelaleti GB, De Campos Zuccari DA.
    Oncol Rep; 2015 Jan; 33(1):311-9. PubMed ID: 25384569
    [Abstract] [Full Text] [Related]

  • 2. Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer.
    León J, Casado J, Carazo A, Sanjuán L, Maté A, Muñoz de Rueda P, de la Cueva P, Quiles R, Ruíz S, Ruíz-Extremera A, Salmerón J.
    Mol Carcinog; 2012 Aug; 51(8):608-18. PubMed ID: 21809392
    [Abstract] [Full Text] [Related]

  • 3. Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection.
    Kaneko Y, Hayashi T, Yu S, Tajiri N, Bae EC, Solomita MA, Chheda SH, Weinbren NL, Parolini O, Borlongan CV.
    J Pineal Res; 2011 Apr; 50(3):272-80. PubMed ID: 21269327
    [Abstract] [Full Text] [Related]

  • 4. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.
    Niles LP, Armstrong KJ, Rincón Castro LM, Dao CV, Sharma R, McMillan CR, Doering LC, Kirkham DL.
    BMC Neurosci; 2004 Oct 28; 5():41. PubMed ID: 15511288
    [Abstract] [Full Text] [Related]

  • 5. Melatonin induces calcium mobilization and influences cell proliferation independently of MT1/MT2 receptor activation in rat pancreatic stellate cells.
    Santofimia-Castaño P, Garcia-Sanchez L, Ruy DC, Sanchez-Correa B, Fernandez-Bermejo M, Tarazona R, Salido GM, Gonzalez A.
    Cell Biol Toxicol; 2015 Apr 28; 31(2):95-110. PubMed ID: 25764371
    [Abstract] [Full Text] [Related]

  • 6. Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines.
    Sánchez-Hidalgo M, Lee M, de la Lastra CA, Guerrero JM, Packham G.
    J Pineal Res; 2012 Nov 28; 53(4):366-73. PubMed ID: 22582944
    [Abstract] [Full Text] [Related]

  • 7. Abnormal melatonin receptor 1B expression in osteoblasts from girls with adolescent idiopathic scoliosis.
    Man GC, Wong JH, Wang WW, Sun GQ, Yeung BH, Ng TB, Lee SK, Ng BK, Qiu Y, Cheng JC.
    J Pineal Res; 2011 May 28; 50(4):395-402. PubMed ID: 21480980
    [Abstract] [Full Text] [Related]

  • 8. Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line.
    Watanabe M, Kobayashi Y, Takahashi N, Kiguchi K, Ishizuka B.
    J Obstet Gynaecol Res; 2008 Aug 28; 34(4):567-73. PubMed ID: 18937711
    [Abstract] [Full Text] [Related]

  • 9. Molecular mechanisms of melatonin anticancer effects.
    Hill SM, Frasch T, Xiang S, Yuan L, Duplessis T, Mao L.
    Integr Cancer Ther; 2009 Dec 28; 8(4):337-46. PubMed ID: 20050373
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of melatonin membrane receptors increases calcium-binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms.
    Das A, Wallace G, Reiter RJ, Varma AK, Ray SK, Banik NL.
    J Pineal Res; 2013 Jan 28; 54(1):58-68. PubMed ID: 22823500
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib exerts antitumor effects in canine mammary tumor cells via COX‑2‑independent mechanisms.
    Tamura D, Saito T, Murata K, Kawashima M, Asano R.
    Int J Oncol; 2015 Mar 28; 46(3):1393-404. PubMed ID: 25571853
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes.
    Radogna F, Paternoster L, De Nicola M, Cerella C, Ammendola S, Bedini A, Tarzia G, Aquilano K, Ciriolo M, Ghibelli L.
    Toxicol Appl Pharmacol; 2009 Aug 15; 239(1):37-45. PubMed ID: 19463840
    [Abstract] [Full Text] [Related]

  • 17. [MT1 melatonin receptors and their role in the oncostatic action of melatonin].
    Danielczyk K, Dziegiel P.
    Postepy Hig Med Dosw (Online); 2009 Sep 15; 63():425-34. PubMed ID: 19837985
    [Abstract] [Full Text] [Related]

  • 18. MT1 and MT2 melatonin receptors play opposite roles in brain cancer progression.
    Kinker GS, Ostrowski LH, Ribeiro PAC, Chanoch R, Muxel SM, Tirosh I, Spadoni G, Rivara S, Martins VR, Santos TG, Markus RP, Fernandes PACM.
    J Mol Med (Berl); 2021 Feb 15; 99(2):289-301. PubMed ID: 33392634
    [Abstract] [Full Text] [Related]

  • 19. Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells.
    Gelaleti GB, Borin TF, Maschio-Signorini LB, Moschetta MG, Hellmén E, Viloria-Petit AM, Zuccari DAPC.
    Vet Comp Oncol; 2017 Dec 15; 15(4):1572-1584. PubMed ID: 28322030
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic actions of melatonin in cancer: possible mechanisms.
    Srinivasan V, Spence DW, Pandi-Perumal SR, Trakht I, Cardinali DP.
    Integr Cancer Ther; 2008 Sep 15; 7(3):189-203. PubMed ID: 18815150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.